IMIBIC — Córdoba, Córdoba

Public research footprint of IMIBIC, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Sarcopenia · Beetroot Juice with Caffeine Co-ingestion · Heart Failure and Preserved Ejection Fraction · Clinically Significant Bacteremia

Recently updated registry entries

NCT06993610 — Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense (Active Not Recruiting)
NCT07661732 — eHealth Lifestyle Intervention To Enhance Outcomes in HFpEF (Not Yet Recruiting)
NCT07552844 — Effects of 8-Week CrossFit-Based Concurrent Training on Fitness, Body Composition, and… (Not Yet Recruiting)

Work at IMIBIC?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.